Susan G. Komen Launches Fall Fundraising Campaign to Accelerate Breast Cancer Research
Event summary
- Susan G. Komen announced its fall calendar of fundraising events, including the 3-Day, Race for the Cure, and MORE THAN PINK Walk, across 30+ U.S. cities from August to November 2026.
- The organization aims to address rising breast cancer incidence, particularly among women under 50, and persistent disparities in mortality rates between Black and white women.
- Andy Grammer will headline the New York City Party in Pink Gala on October 14, 2026, raising funds for breast cancer research and patient support.
- Komen has invested over $3.5 billion in research, patient support, and advocacy since its founding, contributing to 31 of 32 FDA-approved breast cancer drugs in the past 30 years.
The big picture
Susan G. Komen's fall fundraising campaign underscores the urgent need for continued investment in breast cancer research and equitable access to care. With breast cancer incidence rising among younger women and persistent disparities in mortality rates, Komen's comprehensive approach—combining research, patient support, and advocacy—aims to accelerate progress toward a future where no one dies from the disease. The organization's long-standing partnerships with major corporations and its track record of funding groundbreaking research position it as a key player in the fight against breast cancer.
What we're watching
- Fundraising Momentum
- Whether Komen can sustain high participation and donation levels amid rising breast cancer incidence and persistent healthcare disparities.
- Research Impact
- The pace at which Komen-funded research translates into FDA-approved treatments and improved patient outcomes.
- Equity in Care
- How effectively Komen addresses the 40% higher mortality rate among Black women through targeted advocacy and access initiatives.